PCPC Commends House Energy & Commerce Committee Passage on Reauthorization of the Over-the-Counter Monograph Drug User Fee Program, Urges Congress to Adopt Sunscreen Regulatory Reform

Personal Care Products Council / Newsroom / PCPC Commends House Energy & Commerce Committee Passage on Reauthorization of the Over-the-Counter Monograph Drug User Fee Program, Urges Congress to Adopt Sunscreen Regulatory Reform
Statement

PCPC Commends House Energy & Commerce Committee Passage on Reauthorization of the Over-the-Counter Monograph Drug User Fee Program, Urges Congress to Adopt Sunscreen Regulatory Reform

July 24, 2025

FOR IMMEDIATE RELEASE

CONTACTS:

Tesia Williams (202) 297-1232 [email protected]

Team [email protected]

PCPC Commends House Energy & Commerce Committee Passage on Reauthorization of the Over-the-Counter Monograph Drug User Fee Program, Urges Congress to Adopt Sunscreen Regulatory Reform

Washington, D.C. — “The Personal Care Products Council and our member companies commend the House Energy and Commerce Committee on the passage of H.R. 4273, the Over-the-Counter Monograph Drug User Fee Amendments Act. We thank Reps. John Joyce and Debbie Dingell for their continued advocacy on the SAFE Sunscreen Standards Act, which builds on this progress by seeking to align U.S. sunscreen regulations with the latest scientific advancements and global standards. We commend Chairman Brett Guthrie for his commitment to advancing this issue and look forward to supporting enactment as a part of the Over-the-Counter Monograph Drug User Fee Program (OMUFA) reauthorization process.

“OMUFA has helped modernize the regulatory framework for over-the-counter products, like sunscreens, which are vital to consumer safety and well-being. These critical improvements will accelerate U.S. consumers’ access to the most advanced, effective and safest sunscreen UV filters and strengthen global competitiveness.”

 

###

Sunscreen Quality Safety
Secret Link